The Food and Drug Administration and the biopharma industry have agreed in principle on a revamp of the Prescription Drug User Fee Act, by which drug firms provide nearly two-thirds of what the agency...
Pfizer mulls possible OTC Lipitor switch
By
Matthew Arnold
Sep 01, 2011
Pfizer is reportedly weighing an attempt at an over-the-counter switch for Lipitor — a move that could help the company recoup some of its losses when the $11 billion drug loses nationwide exclusivity...